ALBANY, N.Y., April 25, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2017 financialresults before the opening of the market on Tuesday, May 9, 2017. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET.
About AMRIAlbany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product(DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amri-schedules-first-quarter-2017-earnings-release-and-conference-call-300444594.html
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All